Oligonucleotide chip for detection of lamivudine-resistant hepatitis B virus

Journal of Clinical Microbiology

Volumn 42, Issue 9, 2004, Pages 4181-4188

  Jang, Hyunjung ^a   Cho, Mong ^b   Heo, Jeong ^b   Kim, Hyunghoi ^b   Jun, Hongki ^a   Shin, Woowon ^c   Cho, Byungman ^b   Park, Heekyung ^b   Kim, Cheolmin ^b  

^a Pusan National University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Dong A University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; OLIGONUCLEOTIDE; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SITE DIRECTED MUTAGENESIS;

DNA PRIMERS; DNA, VIRAL; DRUG RESISTANCE, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; MUTAGENESIS, SITE-DIRECTED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDE PROBES; SENSITIVITY AND SPECIFICITY;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 4644279101     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.9.4181-4188.2004     Document Type: Article

References (18)

1. Alien, M. I., J. Gauthier, M. DesLauriers, E. J. Bourne, K. M. Carrick, F. Baldanti, L. L. Ross, M. W. Lutz, and L. D. Condreay. 1999. Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine. J. Clin. Microbiol. 37:3338-3347.
2. Chayama, K., Y. Suzuki, M. Kobayashi, M. Kobayashi, A. Tsubota, M. Hashimoto, Y. Miyano, H. Koike, M. Kobavashi, I. Koida, Y. Arase, S. Saitoh, N. Murashima. K. Ikeda, and H. Kumada. 1998. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology 27:1711-1716.
3. Chizhikov, V., A. Rasooly, K. Chumakov, and D. D. Levy. 2001. Microarray analysis of microbial virulence factors. Appl. Environ. Microbiol. 67:3258-3263.
4. Chizhikov, V., M. Wagner, A. Ivshina, Y. Hoshino, A. Z. Kapikian, and K. Chumakov. 2002. Detection and genotyping of human group A rotaviruses by oligonucleotide microarray hybridization. J. Clin. Microbiol. 40:2398-2407.
5. Fischer, K. P., K. S. Gutfreund, and D. L. Tyrrell. 2001. Lamivudine resistance in hepatitis B: mechanisms and clinical implications. Drug Resist. Update 4:118-128.
6. Fukushima, M., K. Kakinuma, H. Hayashi, H. Nagai, K. Ito, and R. Kawaguchi. 2003. Detection and identification of Mycobacterium species isolates by DNA microarray. J. Clin. Microbiol. 41:2605-2615.
7. Jardi, R., M. Buti, F. Rodriguez-Frias, M. Cotrina, X. Costa, C. Pascual, R. Esteban, and J. Guardia. 1999. Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants. J. Virol. Methods 83:181-187.
8. Kirishima, T., T. Okanoue, Y. Daimon, Y. Itoh, H. Nakamura, A. Monta, T. Toyama, and M. Minami. 2002. Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment. J. Hepatol. 37:259-265.
9. Kobayashi, S., T. Ide, and M. Sata. 2001. Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers. J. Hepatol. 34:584-586.
10. Liaw, Y. F. 2002. Management of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B. J. Gastroenterol. Hepatol. 17: S333-S337.
11. Ono, S. K., N. Kato, Y. Shiratori, J. Kato, T. Goto, R. F. Schinazi, F. J. Carrilho, and M. Omata. 2001. The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance. J. Clin. Investig. 107:449-455.
12. Paik, Y. H, H. Y. Chung, W. S. Ryu, K. S. Lee, J. S. Lee, J. H. Kim, C. K. Lee, C. Y. Chon, Y. M. Moon, and K. H. Han. 2001. Emergence of YMDD motif mutant of hepatitis B virus during short-term lamivudine therapy in South Korea. J. Hepatol. 35:92-98.
13. Perrillo, R., E. Schiff, E. Yoshida, A. Statler, K. Hirsch, T. Wright, K. Gutfreund, P. Lamy, and A. Murray. 2000. Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatology 32:129-134.
14. Volokhov, D., A. Rasooly, K. Chumakov, and V. Chizhikov. 2002. Identification of Listeria species by microarray-based assay. J. Clin. Microbiol. 40: 4720-4728.
15. Yang, S. S., C. T. Hsu, J. T. Hu, Y. C. Lai, and C. H. Wu. 2002. Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral hepatitis B. World J. Gastroenterol. 8:868-871.
16. Yeh, C. T., R. N. Chien, C. M. Chu, and Y. F. Liaw. 2000. Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy. Hepatology 31:1318-1326.
17. Zhang, X., Y. Han, Z. Lu, D. Zhang, and Y. Cai. 2000. Detection of hepatitis B virus polymerase variations resistant to lamivudine therapy. Clin. Med. J. 113:455-457.
18. Zoulim, F. 2001. Detection of hepatitis B virus resistance to antivirals. J. Clin. Virol. 21:243-253.